{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:36:08Z","timestamp":1786977368601,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"am","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U10 EY024247"],"award-info":[{"award-number":["U10 EY024247"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["K08EY032202"],"award-info":[{"award-number":["K08EY032202"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY013810"],"award-info":[{"award-number":["P30EY013810"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ogla.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T17:25:31Z","timestamp":1705944331000},"page":"260-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Glaucoma Tube Outcomes with and without Anti-VEGF in Patients with Age-related Macular Degeneration"],"prefix":"10.1016","volume":"7","author":[{"given":"Adam L.","family":"Rothman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavius A.","family":"Beca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Tijerina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M.","family":"Schuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Richard K.","family":"Parrish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Vanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy C.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2024.01.002_bib1","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.ophtha.2015.04.015","article-title":"Use of various glaucoma surgeries and procedures in Medicare beneficiaries from 1994 to 2012","volume":"122","author":"Arora","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.01.002_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ophtha.2020.06.051","article-title":"Trends in glaucoma surgeries performed by glaucoma subspecialists versus nonsubspecialists on Medicare beneficiaries from 2008 through 2016","volume":"128","author":"Rathi","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.01.002_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ajo.2011.10.026","article-title":"Treatment outcomes in the Tube Versus Trabeculectomy (TVT) Study after five years of follow-up","volume":"153","author":"Gedde","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib4","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ophtha.2022.07.003","article-title":"Treatment outcomes in the Primary Tube Versus Trabeculectomy Study after 5\u00a0years of follow-up","volume":"129","author":"Gedde","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.01.002_bib5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0161-6420(87)33321-4","article-title":"Glaucoma filtering surgery with 5-fluorouracil","volume":"94","author":"Rockwood","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.01.002_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/jop.1990.6.175","article-title":"Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma","volume":"6","author":"Chen","year":"1990","journal-title":"J\u00a0Ocul Pharmacol"},{"key":"10.1016\/j.ogla.2024.01.002_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0002-9394(14)71349-2","article-title":"Ocular hypotony after trabeculectomy with mitomycin C","volume":"116","author":"Zacharia","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archopht.1996.01100140151007","article-title":"Endophthalmitis after filtering surgery with mitomycin","volume":"114","author":"Greenfield","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib9","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ophtha.2003.09.037","article-title":"Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation: a prospective randomized clinical trial","volume":"111","author":"Costa","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.01.002_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/112067210501500105","article-title":"The effect of adjunctive Mitomycin C in Ahmed glaucoma valve implantation","volume":"15","author":"Kurnaz","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib11","first-page":"CD011875","article-title":"Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma","volume":"4","author":"Foo","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ogla.2024.01.002_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ogla.2020.10.004","article-title":"Subconjunctival injections of mitomycin C are associated with a lower incidence of hypertensive phase in eyes with Ahmed glaucoma valve","volume":"4","author":"Perez","year":"2021","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2024.01.002_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ogla.2022.11.007","article-title":"Baerveldt aqueous shunt with or without mitomycin C augmentation: a retrospective comparison study","volume":"6","author":"De Sousa Peixoto","year":"2023","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2024.01.002_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogla.2024.01.002_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/ICU.0b013e3283360aad","article-title":"Anti-VEGF therapy for glaucoma","volume":"21","author":"Horsley","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib16","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1167\/iovs.08-2662","article-title":"Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery","volume":"50","author":"Li","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2024.01.002_bib17","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/IJG.0b013e3181efbea5","article-title":"Adjunctive use of bevacizumab versus mitomycin C with Ahmed valve implantation in treatment of pediatric glaucoma","volume":"20","author":"Mahdy","year":"2011","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2024.01.002_bib18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/ceo.13191","article-title":"Effect of subconjunctival bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial","volume":"46","author":"Miraftabi","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/jamaophthalmol.2014.5058","article-title":"Unexpected hypotony after glaucoma drainage implant surgery associated with anti\u2013vascular endothelial growth factor treatment","volume":"133","author":"Hoguet","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ogla.2020.04.005","article-title":"Recurrent tube erosions with anti-vascular endothelial growth factor therapy in patients with age-related macular degeneration","volume":"3","author":"Liu","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2024.01.002_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ogla.2021.08.007","article-title":"Effects of postoperative intravitreal injections on outcomes of traditional glaucoma surgery in patients with preoperative intravitreal injections","volume":"5","author":"Chang","year":"2022","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ogla.2024.01.002_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajo.2005.03.031","article-title":"The Tube Versus Trabeculectomy Study: design and baseline characteristics of study patients","volume":"140","author":"Gedde","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0002-9394(03)00630-5","article-title":"Evaluation of the hypertensive phase after insertion of the Ahmed Glaucoma Valve","volume":"136","author":"Nouri-Mahdavi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib24","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/S0161-6420(03)00803-0","article-title":"Otago Glaucoma Surgery Outcome Study: factors controlling capsule fibrosis around Molteno implants with histopathological correlation","volume":"110","author":"Molteno","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.01.002_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/ICU.0000000000000729","article-title":"History, presence, and future of mitomycin C in glaucoma filtration surgery","volume":"32","author":"Wolters","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ajo.2010.03.025","article-title":"Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study","volume":"150","author":"Kahook","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajo.2011.08.005","article-title":"Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy","volume":"153","author":"Nilforushan","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bjophthalmol-2013-303966","article-title":"Intracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised study","volume":"98","author":"Vandewalle","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ophtha.2014.08.043","article-title":"Five-year treatment outcomes in the Ahmed Baerveldt Comparison Study","volume":"122","author":"Budenz","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.01.002_bib30","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.ophtha.2016.06.035","article-title":"The Ahmed Versus Baerveldt Study: five-year treatment outcomes","volume":"123","author":"Christakis","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.01.002_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajo.2017.01.003","article-title":"Five-year pooled data analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study","volume":"176","author":"Christakis","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ogla.2024.01.002_bib32","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajo.2011.10.024","article-title":"Postoperative complications in the Tube Versus Trabeculectomy (TVT) Study during five years of follow-up","volume":"153","author":"Gedde","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib33","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ophtha.2022.07.004","article-title":"Postoperative complications in the Primary Tube Versus Trabeculectomy Study during 5 years of follow-up","volume":"129","author":"Gedde","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.01.002_bib34","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.ophtha.2011.05.004","article-title":"The Ahmed Versus Baerveldt Study: one-year treatment outcomes","volume":"118","author":"Christakis","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.01.002_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ophtha.2010.07.016","article-title":"Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up","volume":"118","author":"Budenz","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.01.002_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.survophthal.2018.10.008","article-title":"Etiology and management of the hypertensive phase in glaucoma drainage-device surgery","volume":"64","author":"Fargione","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajo.2022.02.027","article-title":"Risk factors for failure of tube shunt surgery: a pooled data analysis","volume":"240","author":"Bowden","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.01.002_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajo.2022.09.006","article-title":"Intraocular pressure changes following stand-alone phacoemulsification: an IRIS Registry analysis","volume":"245","author":"Rothman","year":"2023","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419624000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419624000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T19:11:31Z","timestamp":1728933091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589419624000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2589419624000103"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2024.01.002","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glaucoma Tube Outcomes with and without Anti-VEGF in Patients with Age-related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}